Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial

CitrixNews Staff

· September 28, 2026 at 12:23 PM

Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.

Originally reported by The Hill. Read the full story at the original source.

Former White House ethics attorney Richard Painter said the White House using taxpayer dollars for TV ads promoting Pres...

The Republican gubernatorial nominee in California says schools should go back to English-only classrooms. Steve Hilton...

Image source, PA MediaImage caption, John Healey and cabinet ministers from the other great offices of state gave speech...

Supreme Court Justice Clarence Thomas faces a complicated historical legacy marked by record declines in public trust in...

Related Articles